uniQure N.V. (QURE)
uniQure N.V. (QURE) stock sees increased social media buzz following positive FDA Type A meeting news for AMT-130, fueling hopes for accelerated approval. Unusual options activity shows strong bullish sentiment with significant call buying.
About uniQure N.V.
uniQure N.V. is a biotechnology company focused on gene therapy for severe diseases.
uniQure N.V. uses the ticker $QURE for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- uniQure N.V. (QURE) social dominance is up 148.98% from the previous month.
- uniQure N.V. (QURE) creators is up 50.83% from the previous week.
- uniQure N.V. (QURE) mentions is up 84.67% from the previous week.
Price: $20.50
Price 24-Hour Time-Series Raw Data
The stock price has seen a significant increase, driven by positive news regarding the FDA Type A meeting for AMT-130 and renewed hope for accelerated approval, as reflected in increased social media engagement and positive sentiment. Unusual options activity shows significant call buying at the $70 strike, indicating strong bullish sentiment.
24-Hour: -8.36% 7-Day: -21.99% 30-Day: -10.25%
1-Year High: $70.60 on 2025-10-29
1-Year Low: $8.30 on 2025-04-08
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
uniQure N.V. (QURE) is currently AltRank #494 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +321
[--] Month: [---] +76
[--] Months: [---] +149
[--] Year: [---] +125
1-Year High: [-----] on 2026-01-28
1-Year Low: [--] on 2025-09-27
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] no change
[--] Month: [--] +3
1-Year High: [--] on 2026-01-09
1-Year Low: [--] on 2025-12-11
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] -26%
[--] Month: [---------] +18%
[--] Months: [----------] +339%
[--] Year: [----------] +497%
1-Year High: [---------] on 2025-09-24
1-Year Low: [-----] on 2025-03-08
Engagements by network (24h): YouTube: [--] News: [---] Reddit: [--] X: [------]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +85%
[--] Month: [-----] +13%
[--] Months: [------] +526%
[--] Year: [------] +354%
1-Year High: [-----] on 2025-09-25
1-Year Low: [--] on 2025-04-07
Mentions by network (24h): YouTube: [--] News: [--] Reddit: [--] X: [---]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning uniQure N.V. (QURE) in the last [--] hours which is down 19% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +51%
[--] Month: [---] -6.20%
[--] Months: [-----] +355%
[--] Year: [-----] +543%
1-Year High: [-----] on 2025-09-25
1-Year Low: [--] on 2025-04-07
The most influential creators that mention uniQure N.V. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @peter_mantas | [--] | [-----] | [--] | [-----] |
| @mike98572986 | [--] | [-----] | [--] | [-----] |
| @Tim_Corr | [--] | [---] | [--] | [-----] |
| @TraderNorway | [--] | [---] | [--] | [---] |
| @Prof_Dollar | [--] | [-----] | [--] | [---] |
| @DesertDweller93 | [--] | [-----] | [--] | [---] |
| @jawnzilla | [--] | [---] | [--] | [---] |
| @CryptoProJoe | [--] | [---] | [--] | [---] |
| @BOSSTRADING0 | [--] | [-----] | [--] | [---] |
| @abracabrasian | [--] | [--] | [--] | [---] |
Sentiment: 80%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 83%
[--] Week: 77% +3%
[--] Month: 70% -4%
[--] Months: 70% -14%
[--] Year: 70% -26%
1-Year High: 100% on 2025-03-14
1-Year Low: 40% on 2025-04-14
Most Supportive Themes:
- Positive Clinical Trial Results: (30%) Posts highlight recent positive clinical trial data, suggesting potential for future growth and success in the company's gene therapy treatments.
- Analyst Recommendations: (25%) Users are referencing positive analyst ratings and price targets, indicating a belief that the stock is currently undervalued.
- Stock Picks and Strategies: (20%) QURE is frequently recommended as a stock pick by users sharing investment strategies, suggesting confidence in its market performance.
Most Critical Themes:
- Concerns Over Clinical Trial Data Validity: (40%) Some posts express skepticism regarding the reliability of the clinical trial data and the potential for negative outcomes.
- Market Volatility Concerns: (35%) Users are discussing the impact of overall market conditions and potential volatility on QURE's stock price.
Social Dominance: 0.014%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.014%
Daily Average: 0.025%
[--] Week: 0.074% +0.044%
[--] Month: 0.049% +0.029%
[--] Months: 0.049% +0.038%
[--] Year: 0.049% +0.037%
1-Year High: 0.228% on 2025-09-25
1-Year Low: 0.0049% on 2025-04-07
Market Dominance: 0.00146%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00146%
Daily Average: 0%
1-Year High: 0.116% on 2025-10-31
1-Year Low: 0.00146% on 2026-02-16
Market Cap: $1,289,437,424
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,289,437,424
Daily Average: $2,088,345,752
[--] Week: $1,280,093,675 -19%
[--] Month: $1,276,979,092 -10%
1-Year High: $4,348,610,195 on 2025-10-29
1-Year Low: $761,004,319 on 2025-09-19
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing